Objectives: The World Health Organization (WHO) mentioned Acinetobacter baumannii as a
“priority of concern” in 2017. Acinetobacter baumannii generally infects …

Acinetobacter baumannii (A. baumannii) is a Gram‐negative, nonmotile, and aerobic
bacillus emerged as a superbug, due to increasing the possibility of infection and …

The rapidly increasing threat of multi-drug-resistant Acinetobacter baumannii infections
globally, encompassing a range of clinical manifestations from skin and soft tissue infections …

Background Antimicrobial resistance to ESKAPE pathogens (Enterococcus faecium,
Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas …

Neonatal sepsis (NS) is a leading cause of morbidity and mortality requiring immediate
admission and prolonged neonatal intensive care unit (NICU) stay. This study attempts to …

Urinary tract infections are among the most prevalent types of healthcare-associated
infections (HAIs) in hospitals and nursing homes, and they are primarily a result of …

Background: Carbapenem-resistant Acinetobacter baumannii (CRAB) is a serious global
health challenge. It is increasingly associated with nosocomial infections and outbreaks in …

Acinetobacter baumannii, gram negative bacteria has been a major health threat attributed
to its ability to develop resistance to one of the most effective antibiotics-carbapenems …

The multi-drug-resistant bacterium Acinetobacter baumannii is highly problematic, with
infections ranging from skin and soft tissue, urinary tract infections, meningitis, bacteremia …

Background: Antimicrobial resistance genes are an acquired phenomenon in nosocomial
pathogens as results to uncontrolled and randomly used of antibiotics. Methods: A total of …